WOODWARD PHARMA SERVICES LLC

WOODWARD PHARMA SERVICES LLC specializes in the precise manufacturing of sterile and non-sterile pharmaceutical preparations, with deep expertise in the production of branded and generic oral solid dosage forms, particularly low-volume, high-complexity chemotherapeutic agents such as chlorambucil. The company demonstrates consistent capability in fulfilling urgent, time-sensitive procurement needs for critical oncology medications, indicating advanced formulation science, strict GMP compliance, and agile supply chain responsiveness. Their technical proficiency spans active pharmaceutical ingredient (API) handling, tablet compaction, quality control testing, and batch documentation under 21 CFR Part 211, ensuring regulatory alignment for federal healthcare applications. The contractor maintains a singular, long-standing relationship with the Department of Veterans Affairs, consistently delivering essential oncology therapeutics including Leukeran (chlorambucil) under both routine and emergency procurement protocols. This pattern reflects a trusted, mission-critical role in sustaining the VA’s pharmacopeia for veteran cancer care, with demonstrated capacity to respond rapidly to supply chain disruptions and therapeutic shortages. Their primary focus is pharmaceutical preparation manufacturing under NAICS 325412, positioning them as a niche supplier of specialized, low-volume oral medications critical to institutional healthcare systems. They serve the vertical market of government-sponsored oncology treatment programs, where product consistency, regulatory integrity, and just-in-time delivery are paramount. As a privately held entity based in Wixom, Michigan, WOODWARD PHARMA SERVICES LLC operates without federal certifications such as 8(a), HUBZone, or small business status. Their geographic presence is centralized in Michigan, with a market footprint defined by direct, high-reliability supply to the VA’s national pharmaceutical distribution network. The company’s positioning is that of a mission-critical, single-source manufacturer for niche therapeutics within the federal healthcare ecosystem.